AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 190 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,000 | 0.0% | 122 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 122 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 122 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 122 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | -86.7% | 122 | -82.3% | 0.00% | – |
| Q1 2017 | $15,000 | -76.9% | 688 | -63.1% | 0.00% | – |
| Q4 2016 | $65,000 | -3.0% | 1,863 | -31.6% | 0.00% | – |
| Q3 2016 | $67,000 | -4.3% | 2,722 | -6.9% | 0.00% | – |
| Q2 2016 | $70,000 | -51.7% | 2,924 | -52.8% | 0.00% | -100.0% |
| Q1 2016 | $145,000 | -41.1% | 6,198 | -24.0% | 0.00% | 0.0% |
| Q4 2015 | $246,000 | -41.8% | 8,159 | -23.4% | 0.00% | -50.0% |
| Q3 2015 | $423,000 | -27.9% | 10,649 | +25.4% | 0.00% | -33.3% |
| Q2 2015 | $587,000 | +101.7% | 8,494 | +59.5% | 0.00% | +50.0% |
| Q1 2015 | $291,000 | – | 5,326 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |